Sophiris Bio, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2013
For six months, the company reported revenue of $5,776,456 compared to $9,144,563 a year ago. Net loss before income tax expense was $2,247,371 compared to $10,217,488 a year ago. Net loss was $2,747,371 or $0.02 per basic and diluted share compared to $10,217,488 or $0.07 per basic and diluted share a year ago. Net cash flows used in operating activities was of $1,636,433 compared to $8,584,530 a year ago. Purchase of property and equipment was of $2,742 compared to $20,718 a year ago.